{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:24:02Z","timestamp":1786465442734,"version":"build-2736575974"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,8,11]]},"DOI":"10.1001\/jama.2026.9480","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:30:26Z","timestamp":1784302226000},"page":"453","source":"Crossref","is-referenced-by-count":0,"title":["FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk"],"prefix":"10.1001","volume":"336","author":[{"given":"Samantha","family":"Anderer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2851947\/jama_anderer_2026_ib_260106_1785516201.46932.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:00:20Z","timestamp":1786460420000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2851947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8,11]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.9480","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}